PRESS RELEASE published on 06/07/2024 at 17:45, 1 year 11 months ago Modification des droits attachés aux catégories d'actions Déclaration du nombre de droits de vote et d'actions de Median Technologies au 31 mai 2024. Découvrez les chiffres clés de l'entreprise et ses activités dans l'imagerie médicale et l'IA Euronext Growth Imagerie Médicale Intelligence Artificielle Oncologie Median Technologies
BRIEF published on 05/29/2024 at 17:50, 1 year 11 months ago Median Technologies to Attend 2024 ASCO Annual Meeting in Chicago Clinical Trials Oncology Imaging Solutions Median Technologies ASCO Annual Meeting
BRIEF published on 05/29/2024 at 17:50, 1 year 11 months ago Median Technologies participera à la réunion annuelle de l'ASCO 2024 à Chicago Solutions D'imagerie Essais Cliniques Oncologie Technologies Médianes Réunion Annuelle De L'ASCO
PRESS RELEASE published on 05/29/2024 at 17:45, 1 year 11 months ago Inside Information / Other news releases Median Technologies to participate in the 2024 ASCO Annual Meeting at McCormick Place, Chicago, IL, USA. Abstract on double reading performance in lung clinical trials. Event details and company overview Clinical Trials Oncology Medical Imaging Median Technologies ASCO Annual Meeting
BRIEF published on 05/21/2024 at 17:50, 2 years ago Median Technologies renforce sa position auprès des géants pharmaceutiques Imagerie Médicale Intelligence Artificielle Essais Cliniques Oncologie Median Technologies
BRIEF published on 05/21/2024 at 17:50, 2 years ago Median Technologies strengthens its position with pharmaceutical giants Artificial Intelligence Oncology Medical Imaging Median Technologies Clinical Tests
PRESS RELEASE published on 05/21/2024 at 17:45, 2 years ago Informations privilégiées / Autres communiqués Median Technologies devient fournisseur privilégié d'un nouveau laboratoire pharmaceutique du Top 3 mondial, renforçant ainsi sa position de leader en services d'imagerie pour les essais cliniques en oncologie Oncologie Median Technologies Laboratoire Pharmaceutique Services D'imagerie Accord-cadre De Services
BRIEF published on 05/10/2024 at 17:50, 2 years ago Median Technologies Announces Update on Shares Voting Rights Voting Rights Median Technologies Share Structure French Corporate Law Non-voting Shares
BRIEF published on 05/10/2024 at 17:50, 2 years ago Median Technologies annonce une mise à jour sur les droits de vote des actions Droit De Vote Technologies Médianes Structure De Partage Droit Des Sociétés Français Actions Sans Droit De Vote
PRESS RELEASE published on 05/10/2024 at 17:45, 2 years ago Changes in the rights attaching to the classes of shares or securities Press release about disclosing the total number of voting rights and shares in Median Technologies as of April 30th, 2024 Voting Rights Shares Median Technologies Innovative Imaging Solutions French SME Equity
Published on 05/23/2026 at 00:15, 25 minutes ago Molten Metals Completes Airborne Geophysical Survey at Texas Project
Published on 05/23/2026 at 00:00, 40 minutes ago Redwood AI Announces Collaboration with Resilience Biosciences Inc. to Advance AI-Assisted Small-Molecule Drug Development
Published on 05/22/2026 at 14:04, 10 hours 36 minutes ago Wi2Wi Corporation Announces First Quarter 2026 Financial Results (Unaudited)
Published on 05/22/2026 at 22:05, 2 hours 35 minutes ago Abivax présente ses résultats financiers du T1 2026 et les données à trois ans de l’étude 108, un essai d’extension ouvert de phase 2a/2b évaluant l’obéfazimod après réduction de dose dans la RCH
Published on 05/22/2026 at 22:05, 2 hours 35 minutes ago Abivax Presents Q1 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with UC
Published on 05/22/2026 at 19:51, 4 hours 48 minutes ago Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Redemption Prices
Published on 05/22/2026 at 18:33, 6 hours 7 minutes ago Update on Coupon payment due on 23 May 2026 and Preparation of the Green Bond Restructuring
Published on 05/22/2026 at 18:30, 6 hours 9 minutes ago Annual General Meeting of Curatis Holding AG approved all proposals of the Board of Directors
Published on 05/22/2026 at 19:35, 5 hours 5 minutes ago PROJET D'EVOLUTION DE SA GOUVERNANCE ET LA NOMINATION D'UN PRESIDENT DU DIRECTOIRE PAR INTERIM
Published on 05/22/2026 at 18:05, 6 hours 34 minutes ago Déclaration hebdomadaire d'opérations effectuées du 18 au 22 mai 2026
Published on 05/22/2026 at 18:05, 6 hours 34 minutes ago Disclosure of transactions in own shares from May 18 to May 22, 2026
Published on 05/22/2026 at 12:52, 11 hours 47 minutes ago Communiqué du Conseil d’administration – Assemblée Générale du 22 mai 2026
Published on 05/22/2026 at 12:52, 11 hours 47 minutes ago Release from the Board of Directors - Shareholders’ Meeting of May 22, 2026
